ArticleMolecular neurobiology2026
Molecular Neuroprotective Responses to Achyrocline satureioides Extract in Caenorhabditis elegans: Modulation of Conserved FOXO/NRF2 Pathways and Resistance to Neurotoxic Insults.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achyrocline satureioides is widely consumed as an herbal infusion in South America; however, the toxicological profile of its aqueous extract (ASAE), particularly under conditions of neurotoxic stress, remains incompletely characterized. In the present study, we investigated the safety profile of ASAE and its capacity to modulate chemically induced neurotoxicity by integrating in silico toxicological predictions with in vivo assays in Caenorhabditis elegans. Wild-type and mutant strains deficient in key stress-response regulators (daf-2, daf-16, and skn-1) were exposed to ASAE (10-50 mg/mL). Toxicological and neurofunctional endpoints included survival under methylmercury (MeHg) exposure, PTZ-induced paralysis, locomotor performance, lipofuscin accumulation as a biomarker of oxidative damage, and activation of stress-responsive signaling pathways. Chronic ASAE exposure did not induce developmental toxicity or reduce lifespan at the tested concentrations. Notably, ASAE pre-exposure was associated with reduced behavioral deficits induced by MeHg and delayed PTZ-induced paralysis, indicating reduced susceptibility to chemically induced neurotoxic insults. Mechanistic analyses suggested that these findings are consistent with the involvement of conserved stress-response pathways involving daf-16 and skn-1, regulators functionally analogous to mammalian FOXO and NRF2 signaling. Consistent with these findings, computational toxicology predicted low systemic toxicity for major ASAE constituents and limited interaction with toxicity-related biomarkers. Collectively, these results indicate that ASAE exhibits a favorable toxicological profile and modulates conserved molecular pathways that enhance resilience to neurotoxic stress in C. elegans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.